Western Drug Recalls Super B Comp w/Cyano 3X Inj Due to Sterility Concerns
Western Drug is recalling 15 containers of Super B Comp w/Cyano 3X Inj because the product lacks assurance of sterility. The recall covers all lots distributed nationwide.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class II. According to the rubric, FDA Class II recalls with potential for adverse health consequences (such as lack of sterility in an injectable) map to a score of 4 (Severe), as they are not Class I but involve significant risk.
Plain-English summary
Western Drug Inc. is recalling 15 containers of Super B Comp w/Cyano 3X Inj, a prescription injectable product. The recall was initiated because the product lacks assurance of sterility. The affected product is distributed nationwide in the United States, specifically in Arizona, California, Georgia, New Mexico, South Carolina, South Dakota, Texas, and Utah.
The recall covers all lots of the product. No specific lot numbers are provided in the source text. The product is a prescription item, meaning it is typically dispensed by healthcare providers rather than sold directly to consumers in retail settings.
Consumers and healthcare providers who have this product should stop using it and contact their healthcare provider or the recalling firm for further instructions. The FDA classifies this recall as Class II, indicating that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
The recalled product
- Product
- Super B Comp w/Cyano 3X Inj, Rx, Western Drug Inc. 106 E. Main Street, Springerville, Arizona 85938
- Manufacturer
- Western Drug
- Category
- Drug — Injectable
- Hazard
- Affected units
- 15
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- all lots
Distribution
Part of a larger recall action
This product is one of 91 recalled by Western Drug under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 91 products in this recall →Related recalls
Same manufacturer · Western Drug
See all →- SevereWestern Drug Recalls Sodium Hydroxide 10% Injection Due to Sterility Concerns
FDA (Drugs) · 2015-12-09
- SevereWestern Drug Recalls Methylcobalamin Injection Due to Sterility Concerns
FDA (Drugs) · 2015-12-09
- SevereWestern Drug Recalls Benadryl Injection Due to Sterility Concerns
FDA (Drugs) · 2015-12-09
- SevereWestern Drug Recalls PZI 40 Insulin Due to Sterility Concerns
FDA (Drugs) · 2015-12-09
- SevereWestern Drug Recalls Ketorolac Injection Due to Sterility Concerns
FDA (Drugs) · 2015-12-09
Same hazard · lack of sterility
See all →- SevereK.C. Pharmaceuticals Recalls Dry Eye Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Multiple Brands of Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereClear Eyes Redness Relief Eye Drops Recalled for Sterility Assurance Issues
FDA (Drugs) · 2026-09-30
- SevereGentle Eyes Lubricant Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
Similar recalls
- SevereGreen Valley Drugs Recalls B-Complex Injections Due to Sterility Concerns
FDA (Drugs) · 2013-05-22
- SevereSpecialty Medicine Compounding Pharmacy Recalls WB-Tranexamic Acid Due to Sterility Concerns
FDA (Drugs) · 2014-01-22
- SevereRed Mountain Compounding Recalls S-Vit B Complex Injection for Sterility Concerns
FDA (Drugs) · 2019-11-13
- SevereAxia Pharmaceutical Recalls B-Complex 110 Injectable Due to Sterility Concerns
FDA (Drugs) · 2020-03-11
- HighTRI-MIX 30/1/20 Injectable Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2022-09-21
- HighInjectable drug recalled due to lack of sterility assurance
FDA (Drugs) · 2022-09-21